Date: 2016-03-16
Type of information: Nomination
Compound:
Company: Kite Pharma (USA - CA)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On March 16, 2016, Kite Pharma announced the appointment of Tim Moore as Executive Vice President, Technical Operations. With more than three decades of industry experience, Mr. Moore will be responsible for product development, manufacturing, supply chain, quality assurance, and end-to-end process optimization for all aspects of Kite's engineered T cell product candidates. Mr. Moore will report to Arie Belldegrun , M.D., FACS, Chairman, President, and Chief Executive Officer.
Mr. Moore joins Kite Pharma from Genentech, where he served most recently as Senior Vice President and Global Head of Pharmaceutical Technical Operations Biologics and a member of the Genentech Executive Committee. In this position, he oversaw global manufacturing and end-to-end quality supply performance of more than 20 biological product families totaling more than $28 billion in sales, across 150 countries, 7,500 professionals and 10 internal manufacturing sites. Mr. Moore's previous roles at Genentech include Senior Vice President, Global Supply Chain , Vice President, South San Francisco Manufacturing, and Vice President, Corporate Engineering. Prior to joining Genentech , he served as Vice President, Operations at ZLB Behring (formerly Aventis Behring ). Mr. Moore has also held engineering positions at Merck & Co. He holds a BS in chemical engineering from the University of Tulsa , and an MS in engineering management from Northwestern University .
Financial terms:
Latest news:
